Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-25-025185
Filing Date
2025-02-12
Accepted
2025-02-12 17:07:00
Documents
20
Effectiveness Date
2025-02-12

Document Format Files

Seq Description Document Type Size
1 S-3ASR d915440ds3asr.htm S-3ASR 294727
2 EX-4.9 d915440dex49.htm EX-4.9 297438
3 EX-5.1 d915440dex51.htm EX-5.1 23848
4 EX-23.1 d915440dex231.htm EX-23.1 1899
5 EX-23.2 d915440dex232.htm EX-23.2 1955
6 EX-FILING FEES d915440dexfilingfees.htm   iXBRL EX-FILING FEES 55336
7 GRAPHIC g915440dsp54.jpg GRAPHIC 4564
8 GRAPHIC g915440dsp55.jpg GRAPHIC 1633
9 GRAPHIC g915440g00a03.jpg GRAPHIC 32443
  Complete submission text file 0001193125-25-025185.txt   940662

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT d915440dexfilingfees_htm.xml XML 44239
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-284878 | Film No.: 25615921
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)